• YouTube
    • Facebook

    GRESP GRESP

    • Início
    • Sobre Nós
      • Comissão Coordenadora
      • Objetivos
      • Grupos de Trabalho
        • Doença Pulmonar Obstrutiva Crónica
        • Asma e Rinite
        • Apneia do Sono e Cuidados Respiratórios Domiciliários
        • Doenças Infeciosas
        • Doenças Oncológicas Respiratórias
        • Reabilitação Respiratória
        • Tabagismo
        • Dispositivos inalatórios
        • Formação e Investigação
        • Prevenção
        • Comunicacao e Digital
        • Avaliação Funcional Respiratória
      • Patrocínio Científico
      • Novas Inscrições
    • Eventos
    • Recursos
      • Minuto GRESP
      • Folhetos / Guias práticos
      • Vídeos
        • Dispositivos Inalatórios e Técnica Inalatória
        • Reabilitação Respiratória
      • Testes e questionários
        • ADO Index
        • BODE e BODEx
        • DOSE
        • Measurement of Health-Related Quality of Life & Asthma Control
      • Recursos por tema
        • Asma e Rinite
        • DPOC
        • Avaliação funcional respiratória
        • SAOS e CRD
        • Dispositivos inalatórios e técnica inalatória
        • Doenças respiratórias infeciosas
        • Tabagismo
        • Vacinação
      • Leituras / Discussão
    • Galeria
    • Contatos
    • Links Úteis

    A Não Perder

    • Little agreement in GOLD category using CAT and mMRC in 450 primary care COPD patients in New Zealand
    • The challenge of objective confirmation of asthma diagnosis in primary care
    • Primary Care Interventions to Prevent Tobacco Use in Children and Adolescents: U.S. Preventive Services Task Force Recommendation Statement
    • [ BROKEN LINK ] Position statement on e-cigarettes by American Thoracic Society
    • The Asthma Control Questionnaire as a clinical trial endpoint: past experience and recommendations for future use
    • International ERS/ATS Guidelines on Definition, Evaluation and Treatment of Severe Asthma
    • Using community level strategies to reduce asthma attacks triggered by outdoor air pollution: a case crossover analysis
    • Would today’s international agreements prevent another outbreak like SARS?
    • Allergic rhinitis in children
    • Fatores determinantes da qualidade de vida numa população de doentes com doença pulmonar obstrutiva crónica
    • Inhaler devices in asthma and COPD – An assessment of inhaler technique and patient preferences.
    • [ BROKEN LINK ] Evaluation of allergic rhinitis and asthma control in a Portuguese community pharmacy setting.
    • White Paper Long-Acting Muscarinic Agents (LAMAs)
    • Ensuring the future of health information online
    • Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2–4 COPD: results from two replicate 48-week studies
    • Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012–2013
    • Outcomes and costs of treating chronic obstructive pulmonary disease with inhaled fixed combinations: the Italian perspective of the PATHOS study
    • Activity restriction in mild COPD: a challenging clinical problem
    • Depression and anxiety predict health-related quality of life in chronic obstructive pulmonary disease: systematic review and meta-analysis
    • Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis
    • An online survey to study the relationship between patients’ health literacy and coping style and their preferences for self-management-related information
    • Living in negotiation: patients’experiences of being in the diagnostic process of COPD
    • New combination treatments in the management of asthma: focus on fluticasone/vilanterol
    • Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23

    Gresp no Facebook

    Siga-nos no Facebook e fique a par de todas as novidades na área das doenças respiratórias.

    APMGFIPCRG

    Contatos

    Mail: gresp@apmgf.pt

    • Novas inscrições
    • Patrocínio científico

    Associação Portuguesa de Medicina Geral e Familiar

    Av. da República, 97 – 1.º
    1050-190 Lisboa – Portugal
    Telf. +351 217 615 250
    Fax: +351 217 933 145

    © 2025 GRESP. Todos os direitos reservados